From research idea to Real-World data: advance Precision Medicine with multimodal data infrastructure.
Axia generates novel, purpose-built datasets that do not exist in the market, scoped to your specific research requirements.
Turn a research idea into an executable data project.
You define the criteria that matters: cohorts, modalities, geography. AXIA assesses feasibility across care providers and data sources, identifying what exists today and what new real-world insights can be responsibly generated.
Multimodal data, including across genomics, transcriptomics, wearables, clinical biomarkers and Real-World outcomes, are harmonised and accessed within regulatory-ready environments, providing a defensible foundation for multiomics work.
One partner. One contract. A fully priced project.
AXIA acts as a single accountable counterparty for your project. We manage care provider participation, patient consent workflows, sequencing or assay partners, and data access logistics, allowing partners to request and analyse federated cohorts without coordinating multiple institutions.
All activity occurs within audited, regulatory-ready environments designed to operate across jurisdictions. AXIA standardises governance and auditability, reducing legal complexity and internal review cycles when working internationally.
Extend projects without starting from zero.
Axia provides a governed, opt-in mechanism for patient participation that does not require sponsors to directly manage engagement. Participation is structured, transparent, and aligned with existing consent frameworks.
This enables longitudinal follow-up, additional measurements, or new data requests without repeating recruitment or rebuilding consent. Follow-on work is structured as scoped extensions, avoiding repeated contracting cycles or fragmented site coordination.
Connect with Axia to shape the future of real-world, multimodal data research
Patrick C, Head of Biomarker Discovery
“Omics data is essential for work, research, but even the largest datasets cannot support every analytical question.
And when a dataset doesn’t have enough statistical power for your question, there is no way to add more data, especially when Omics is missing.
Axia’s model means we finally have a place to go to fill those evidence gaps.”
